Trial · NCT07882277
27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery
NCT07882277, Not applicable, Not yet recruiting, Metehan Uzundal
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. 27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery. Trials, record NCT07882277. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882277
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- 27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery
- NCT number
- NCT07882277
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 70 participants, estimated
- Lead sponsor
- Metehan Uzundal
- Conditions
- Endometrial Cancer
- Interventions
- 27-Inch Endoscopic Imaging Monitor, 55-Inch Endoscopic Imaging Monitor
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Operative Time | During surgery | Total operative time, defined as the time from entry of the laparoscopic optic into the abdomen after trocar placement to completion of surgery, measured in minutes. |
| Secondary | Bilateral Pelvic Sentinel Lymph Node Dissection Time | During surgery | Time required to complete bilateral pelvic sentinel lymph node dissection, measured in minutes. |
| Secondary | Number of Retrieved Sentinel Lymph Nodes | From surgery to final pathology assessment, up to 30 days after surgery | Number of right and left sentinel lymph nodes removed during surgery. |
| Secondary | Hemoglobin Decrease | Preoperative to postoperative 24 hours | Percentage decrease in hemoglobin level calculated using preoperative and postoperative 24-hour hemoglobin values. |
| Secondary | Hematocrit Decrease | Preoperative to postoperative 24 hours | Percentage decrease in hematocrit level calculated using preoperative and postoperative 24-hour hematocrit values. |
| Secondary | Blood Transfusion Requirement | From start of surgery to hospital discharge, up to 30 days after surgery | Need for perioperative or postoperative blood transfusion, recorded as yes or no. |
| Secondary | Intraoperative Complications | During surgery | Occurrence of any intraoperative complication, recorded as yes or no. |
| Secondary | Postoperative Complications Within 30 Days | Up to 30 days after surgery | Occurrence of any postoperative complication within 30 days after surgery, recorded as yes or no. |
| Secondary | Postoperative Infections Within 30 Days | Up to 30 days after surgery | Occurrence of postoperative infection within 30 days after surgery, recorded as yes or no. |
| Secondary | Clavien-Dindo Complication Grade | Up to 30 days after surgery | Severity of postoperative complications classified according to the Clavien-Dindo classification |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882277
GET https://conductscience.org/api/trials/v1/NCT07882277/registered